These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 9923553)
1. Effects of amifostine on perfused isolated rat heart and on acute doxorubicin-induced cardiotoxicity. Nazeyrollas P; Prévost A; Baccard N; Manot L; Devillier P; Millart H Cancer Chemother Pharmacol; 1999; 43(3):227-32. PubMed ID: 9923553 [TBL] [Abstract][Full Text] [Related]
2. Efficiency of amifostine as a protection against doxorubicin toxicity in rats during a 12-day treatment. Nazeyrollas P; Frances C; Prevost A; Costa B; Lorenzato M; Kantelip JP; Elaerts J; Millart H Anticancer Res; 2003; 23(1A):405-9. PubMed ID: 12680240 [TBL] [Abstract][Full Text] [Related]
3. A short-time model to study relevant indices of cardiotoxicity of doxorubicin in the rat. Hole LD; Larsen TH; Fossan KO; Limé F; Schjøtt J Toxicol Mech Methods; 2013 Jul; 23(6):412-8. PubMed ID: 23379389 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the protective effects of amifostine and dexrazoxane against the toxicity of doxorubicin in spontaneously hypertensive rats. Herman EH; Zhang J; Chadwick DP; Ferrans VJ Cancer Chemother Pharmacol; 2000; 45(4):329-34. PubMed ID: 10755322 [TBL] [Abstract][Full Text] [Related]
5. The efficacy of selenium, WR-2721, and their combination in the prevention of adriamycin-induced cardiotoxicity in rats. Dobrić S; Dragojević-Simić V; Bokonjić D; Milovanović S; Marincić D; Jović P J Environ Pathol Toxicol Oncol; 1998; 17(3-4):291-9. PubMed ID: 9726805 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of anthracycline cardiotoxicity with the model of isolated, perfused rat heart: comparison of new analogues versus doxorubicin. Pouna P; Bonoron-Adèle S; Gouverneur G; Tariosse L; Besse P; Robert J Cancer Chemother Pharmacol; 1995; 35(3):257-61. PubMed ID: 7805186 [TBL] [Abstract][Full Text] [Related]
8. Effects of three new anthracyclines and doxorubicin on the rat isolated heart. Chen ZM; Colombo T; Conforti L; Grazia Donelli M; Fiedorowicz RJ; Marchi S; Paolini A; Riva E; Zuanetti G; Latini R J Pharm Pharmacol; 1987 Nov; 39(11):947-50. PubMed ID: 2892924 [TBL] [Abstract][Full Text] [Related]
9. Amifostine protects against early but not late toxic effects of doxorubicin in infant rats. Jahnukainen K; Jahnukainen T; Salmi TT; Svechnikov K; Eksborg S; Söder O Cancer Res; 2001 Sep; 61(17):6423-7. PubMed ID: 11522636 [TBL] [Abstract][Full Text] [Related]
10. FGF-2 and FGF-16 protect isolated perfused mouse hearts from acute doxorubicin-induced contractile dysfunction. Sontag DP; Wang J; Kardami E; Cattini PA Cardiovasc Toxicol; 2013 Sep; 13(3):244-53. PubMed ID: 23430353 [TBL] [Abstract][Full Text] [Related]
11. Acute effects of gallium chloride on ventricular function and metabolism of the Langendorff perfused rat heart. Millart H; Leperre A; Kantelip JP; Collery P; Descous I; Trenque T; Lamiable D Anticancer Res; 1993; 13(6A):2251-6. PubMed ID: 8297141 [TBL] [Abstract][Full Text] [Related]
12. The effects of isosteviol against myocardium injury induced by ischaemia-reperfusion in the isolated guinea pig heart. Xu D; Zhang S; Foster DJ; Wang J Clin Exp Pharmacol Physiol; 2007; 34(5-6):488-93. PubMed ID: 17439420 [TBL] [Abstract][Full Text] [Related]
13. Effects of dexrazoxane and amifostine on evolution of Doxorubicin cardiomyopathy in vivo. Bjelogrlic SK; Radic J; Radulovic S; Jokanovic M; Jovic V Exp Biol Med (Maywood); 2007 Dec; 232(11):1414-24. PubMed ID: 18040065 [TBL] [Abstract][Full Text] [Related]
14. Cardioprotection of rat heart myocytes with amifostine (Ethyol) and its free thiol, WR-1065, in vitro. Dorr RT; Lagel K; McLean S Eur J Cancer; 1996; 32A Suppl 4():S21-5. PubMed ID: 8976818 [TBL] [Abstract][Full Text] [Related]
15. Acute doxorubicin cardiotoxicity: functional, metabolic, and morphologic alterations in the isolated, perfused rat heart. Pelikan PC; Weisfeldt ML; Jacobus WE; Miceli MV; Bulkley BH; Gerstenblith G J Cardiovasc Pharmacol; 1986; 8(5):1058-66. PubMed ID: 2429080 [TBL] [Abstract][Full Text] [Related]
16. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration. Saad SY; Najjar TA; Alashari M J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649 [TBL] [Abstract][Full Text] [Related]
17. Antagonism of doxorubicin cardiotoxicity by carnitine is specific of the L-diasteroisomer. Maccari F; Ramacci MT Biomedicine; 1981 May; 35(2):65-7. PubMed ID: 7260239 [TBL] [Abstract][Full Text] [Related]
18. Acute exercise protects against doxorubicin cardiotoxicity. Wonders KY; Hydock DS; Schneider CM; Hayward R Integr Cancer Ther; 2008 Sep; 7(3):147-54. PubMed ID: 18815146 [TBL] [Abstract][Full Text] [Related]
19. Investigation of doxorubicin tissue toxicity: does amifostine provide chemoprotection? An experimental study. Rigatos SK; Stathopoulos GP; Dontas I; Perrea-Kotsarelis D; Couris E; Karayannacos PE; Deliconstantinos G Anticancer Res; 2002; 22(1A):129-34. PubMed ID: 12017274 [TBL] [Abstract][Full Text] [Related]
20. Protective effect of paracetamol in doxorubicin-induced cardiotoxicity in ischemia/reperfused isolated rat heart. Hesari M; Shackebaei D; Asadmobini A Anatol J Cardiol; 2018 Feb; 19(2):94-99. PubMed ID: 29350208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]